Home
About
News & Events

News & Events

Fibroblast Activity and ECM Turnover | Webinar

Fibroblast Activity and ECM Turnover: Biomarkers for Outcomes in Fibrosis and Cancer Join this webinar to explore why the extracellular matrix (ECM) sits at the center of chronic disease and why fibroblast activity is emerging as a practical, quantifiable lever for prognosis and drug development across fibrosis and oncology. We will highlight key takeaways from over […]

Read article

Latest events January 22, 2026

AD/PD 2026

Nordic Bioscience’s neurology team will attend this year’s AD/PD conference in Copenhagen, Denmark. It will take place from March 17-21 and revolve around Alzheimer’s and Parkinson’s diseases. Our team will bring four posters, which will cover the following topics: There will also be a oral presentation on how the blood-based biomarker TAU-C is related to […]

Read article

Latest events January 21, 2026

ECCO 2026

Nordic Bioscience’s gastroenterology team will be attending ECCO 2026, held February 18–21, 2026, in Stockholm, Sweden. As one of the most influential congresses in inflammatory bowel disease, ECCO provides a focused setting for scientific exchange across clinical practice, translational research, and drug development. At this year’s meeting, we will be exhibiting and highlighting CPa9-HNE™, our […]

Read article

Latest events January 6, 2026

CAFs and the ECM | Webinar

January 26, 2026 Join this ECM Pharmacology Symposium to explore how cancer-associated fibroblasts (CAFs) and the extracellular matrix (ECM) operate as functional units that shape tumor biology — and how these mechanisms can be translated into clinically useful readouts. The session connects mechanistic insights from human pancreatic and breast cancer with emerging non-invasive ECM-derived biomarkers […]

Read article

Latest events October 6, 2025

Endotrophin & PRO-C6 | Webinar

Collagen VI Biomarkers for Mechanism, Prognosis, and Drug Development Overview Type VI collagen sits at the intersection of fibroblast activation, fibrogenesis, and wound healing. Two assays quantify distinct aspects of this axis: Together, these assays provide complementary insights: PRO-C6 reflects total collagen VI formation, while Endotrophin isolates the signaling activity of Endotrophin, offering a more […]

Read article

Autumn Conference Season (Q3-Q4)

Find an overview of the conferences Nordic Bioscience will be attending in Q3-Q4. A busy yet exciting period lies ahead of us, as we will attend various conferences in the next months. You can meet our team in a range of locations in both Europe and the US. Here we will present our newest insights […]

Read article

News

Madrigal Pharmaceuticals Takes a Major Step Toward Improving the Lives of NASH Patients with the Help of the PRO-C3 Biomarker

December 20, 2022

Read article

NEJM Evidence Study on PRO-C6 Followed up by Two Editorials

September 30, 2022

Read article

PRESS RELEASE: Research Published in NEJM Evidence Positions Nordic Bioscience’s PRO-C6 as Next-Generation Biomarker Assay for Trial Enrichment in HFpEF

September 14, 2022

Read article

1 … 4 5 6 7 8

Upcoming events

ECCO 2026

February 18, 2026

–

February 21, 2026

Stockholm, Sweden

View event

AD/PD 2026

March 17, 2026

–

March 21, 2026

Copenhagen, Denmark

View event

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

What we offer

Biomarker portfolio

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Our services

Lab solutions

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Measure specific protein fragments

Our technology

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

About Nordic Bioscience

Who we are

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

News & Events

Fibroblast Activity and ECM Turnover | Webinar

AD/PD 2026

ECCO 2026

CAFs and the ECM | Webinar

Endotrophin & PRO-C6 | Webinar

Autumn Conference Season (Q3-Q4)

News

Madrigal Pharmaceuticals Takes a Major Step Toward Improving the Lives of NASH Patients with the Help of the PRO-C3 Biomarker

NEJM Evidence Study on PRO-C6 Followed up by Two Editorials

PRESS RELEASE: Research Published in NEJM Evidence Positions Nordic Bioscience’s PRO-C6 as Next-Generation Biomarker Assay for Trial Enrichment in HFpEF

Research on Biomarkers of Tissue Turnover Show Disease Severity and Activity in Hidradenitis Suppurativa

Nordic Bioscience Landing a Multi-Million Deal with Danish Pharmaceutical

New Nintedanib Research to Assess Pulmonary Fibrosis

Upcoming events

ECCO 2026

AD/PD 2026